Testing revealed weight loss effects some Wall Street analysts believe compare favorably to Lilly’s orforglipron, which ...

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

The CBSE Class 12th Economics Exam Analysis for 2026 provides a detailed review, including the question paper's difficulty level, structure, and expert/student feedback. Check expected performance and ...

Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong cash runway.

ZJK Industrial Co., Ltd. (NASDAQ: ZJK) ('ZJK Industrial”, 'ZJK” or the 'Company”), a high-tech enterprise specializing in the manufacturing and sale of precision fasteners, structural parts and other ...

Egypt-based Beltone Asset Management has secured initial FRA approval to launch “Fadda”, Egypt’s first silver investment fund with cumulative daily returns, introducing a new alternative asset class ...

SEC Chair Paul Atkins said the new securities guidance, which impacts "most crypto assets," provides "clear lines in clear ...

Learn how foreign companies can structure operations in Indonesia to manage corporate tax, reduce withholding exposure, and ...

A high school teacher describes how she teaches her students that disciplinary literacy is more than ‘fancy’ vocabulary.

The exam was conducted today, March 18. Download the question paper PDF, check the detailed exam analysis, and review the answer key to evaluate your performance.

Analysts remain intrigued by aleniglipron’s potential in the oral GLP-1RA market, though they note it is too early to compare the drug’s efficacy to Eli Lilly’s orforglipron.

In a letter written to Ranjana Desai, chairperson, 8th Pay Commission, KV Ramesh, secretary general, IRTSA, wrote that ...